Annovis Bio, Inc. Annual Operating Income (Loss) in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Annovis Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
  • Annovis Bio, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$6.73M, a 35.5% increase year-over-year.
  • Annovis Bio, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$26.7M, a 40.7% increase year-over-year.
  • Annovis Bio, Inc. annual Operating Income (Loss) for 2024 was -$26.7M, a 40.7% increase from 2023.
  • Annovis Bio, Inc. annual Operating Income (Loss) for 2023 was -$45M, a 76.5% decline from 2022.
  • Annovis Bio, Inc. annual Operating Income (Loss) for 2022 was -$25.5M, a 75.5% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$26.7M +$18.3M +40.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-21
2023 -$45M -$19.5M -76.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-21
2022 -$25.5M -$11M -75.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$14.5M -$7.9M -119% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$6.64M -$5.03M -314% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 -$1.61M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.